# Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes

> **NCT01584323** · NA · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 100 (estimated)

## Conditions studied

- Preterm Premature Rupture of Membranes
- Pregnant State

## Interventions

- **DIETARY_SUPPLEMENT:** Pomgranate pills
- **DIETARY_SUPPLEMENT:** Placebo pills

## Key facts

- **NCT ID:** NCT01584323
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584323, "Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01584323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*